Working… Menu
Trial record 19 of 23 for:    betadex

Safety, Tolerability and Pharmacokinetics of Single Rising Doses of BIIB 722 CL and HPβCD in Young Healthy Male Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02224079
Recruitment Status : Completed
First Posted : August 25, 2014
Last Update Posted : August 25, 2014
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 2002
Study Completion Date : No date given